Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD-295 Phase III Study
jRCT2080221891Phase 3
- Sponsor
- The Chemo-Sero-Therapeutic Research Institute
- Start
- Aug 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of KD-295 in Infectious disease, sponsored by The Chemo-Sero-Therapeutic Research Institute.
02
Drugs
KD-295
03
Conditions
Infectious disease
Beyond the preview
Go deeper on jRCT2080221891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221891.